Published in Am J Orthopsychiatry on April 01, 2000
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull (2009) 3.78
Intensive case management for severe mental illness. Cochrane Database Syst Rev (2010) 2.51
Vocational rehabilitation for people with severe mental illness. Cochrane Database Syst Rev (2001) 2.12
How evidence-based practices contribute to community integration. Community Ment Health J (2004) 1.76
Helping people with severe mental illness to obtain work: systematic review. BMJ (2001) 1.66
Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophr Bull (2009) 1.40
Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US. World Psychiatry (2012) 1.27
Review of critical factors related to employment after spinal cord injury: implications for research and vocational services. J Spinal Cord Med (2009) 1.26
Supported employment outcomes of a randomized controlled trial of ACT and clubhouse models. Psychiatr Serv (2006) 1.19
Randomized trial of supported employment integrated with assertive community treatment for rural adults with severe mental illness. Schizophr Bull (2005) 1.17
Portland identification and early referral: a community-based system for identifying and treating youths at high risk of psychosis. Psychiatr Serv (2010) 1.11
The potential impact of the recovery movement on family interventions for schizophrenia: opportunities and obstacles. Schizophr Bull (2006) 1.07
Attitudes and perceived barriers to working with families of persons with severe mental illness: mental health professionals' perspectives. Community Ment Health J (2008) 0.88
Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI. Community Ment Health J (2010) 0.84
Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis. Schizophr Res (2013) 0.81
Family involvement and satisfaction with community mental health care of individuals with schizophrenia. Community Ment Health J (2005) 0.78
The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophr Res (2010) 0.76
The effect of IPS-modified, an early intervention for people with mood and anxiety disorders: study protocol for a randomised clinical superiority trial. Trials (2013) 0.75
Effectiveness of a brief psychoeducational group intervention for relatives on the course of disease in patients after inpatient depression treatment compared with treatment as usual - study protocol of a multisite randomised controlled trial. BMC Psychiatry (2015) 0.75
Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med (1978) 7.97
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Survival after 40 minutes; submersion without cerebral sequeae. Lancet (1975) 2.88
Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest (1976) 2.84
Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet (1971) 2.64
Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci U S A (1980) 2.61
Risk factors for homelessness. Epidemiol Rev (1993) 2.55
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology (1995) 2.24
Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol (1973) 2.08
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 1.99
HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum (1990) 1.90
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
Time of appearance and distribution of cells capable of secondary immune response following primary immunization. Immunology (1967) 1.84
The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol (1984) 1.81
A new antigen system expressed in human endothelial cells. J Clin Invest (1977) 1.79
Multidisciplinary management of Hunter syndrome. Pediatrics (2009) 1.76
Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.74
Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry (1995) 1.70
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol (2010) 1.64
Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis. Arch Neurol (1992) 1.47
MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics (1998) 1.43
No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-2001. Thorax (2005) 1.43
Home hazards and falls in the elderly: the role of health and functional status. Am J Public Health (1995) 1.41
Location of Golgi membranes with reference to dividing nuclei in syncytial Drosophila embryos. Proc Natl Acad Sci U S A (1994) 1.41
Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest (1979) 1.38
PCB-blood levels in teachers, working in PCB-contaminated schools. Chemosphere (2000) 1.34
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
Mental patient status, work, and income: an examination of the effects of a psychiatric label. Am Sociol Rev (1982) 1.26
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
The human immune response region (HLA-D) and disease susceptibility. Immunol Rev (1983) 1.24
Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc (1970) 1.23
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin Exp Immunol (1973) 1.23
HLA-D region-associated determinants serve as targets for human cell-mediated lysis. J Exp Med (1979) 1.22
Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22
Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation. J Immunol (1983) 1.22
Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol (1986) 1.20
Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol (2000) 1.18
HLA-Dw4 in adult and juvenile rheumatoid arthritis. Transplant Proc (1977) 1.15
Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab. J Clin Oncol (1999) 1.14
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.12
Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest (2000) 1.12
Lymphokines in rheumatoid synovitis. Ann N Y Acad Sci (1975) 1.11
Immunogenetic factors in preeclampsia and eclampsia. Erythrocyte, histocompatibility, and Y-dependent antigens. JAMA (1976) 1.11
Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease. J Clin Invest (1974) 1.11
DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum Immunol (1992) 1.10
Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J Immunol (1986) 1.09
Age and recognition of depression: implications for a cohort effect in major depression. Psychol Med (1988) 1.08
Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol (1999) 1.08
Psychoeducational multiple family groups: four-year relapse outcome in schizophrenia. Fam Process (1995) 1.07
Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. J Immunol (1984) 1.06
Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets. Immunogenetics (1982) 1.06
Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05
Typing for all known MICA alleles by group-specific PCR and SSOP. Hum Immunol (2001) 1.04
HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol (1988) 1.04
Experimental arthritis produced by injection of mediators of delayed hypersensitivity. Arthritis Rheum (1974) 1.03
Family-aided assertive community treatment: a comprehensive rehabilitation and intensive case management approach for persons with schizophrenic disorders. New Dir Ment Health Serv (1992) 1.03
Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus. Arthritis Rheum (1972) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Contribution of family, cognitive and clinical dimensions to long-term outcome in schizophrenia. Schizophr Res (1992) 1.00
Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease. Neurology (1981) 1.00
Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity. Ann Oncol (1999) 0.99
Testosterone-binding globulins in human plasma: studies on sex distribution and specificity. J Clin Invest (1968) 0.98
The location of the nucleolus organizer regions in Drosophila hydei. Chromosoma (1975) 0.97
Monoclonal antibodies against human monocytes. II. Recognition of two distinct cell surface molecules. Scand J Immunol (1982) 0.97
Lymphocyte and platelet autoantibodies in S.L.E. Lancet (1971) 0.97
Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol (1985) 0.97
Restriction fragment length polymorphism of the gene encoding the alpha chain of the human T cell receptor. J Exp Med (1985) 0.96
Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med (1988) 0.96
Acute health effects among firefighters exposed to a polyvinyl chloride (PVC) fire. Am J Epidemiol (1989) 0.95
Development of immunological memory during the primary immune response. Nature (1967) 0.95
HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics (1991) 0.95
Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med (1988) 0.94
Juvenile arthritis and autoimmunity to type II collagen. Arthritis Rheum (2001) 0.94
High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest (1981) 0.93
Genetic markers for susceptibility to endemic Brazilian pemphigus foliaceus (Fogo Selvagem) in Xavante Indians. Tissue Antigens (1993) 0.93
HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant (2009) 0.93
Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens (1993) 0.93
HLA class II haplotypes in Amerindians and in black North and South Americans. Tissue Antigens (1991) 0.93
Studies on the relationship between HLA DR4 and in vitro IgM rheumatoid factor production. Clin Immunol Immunopathol (1983) 0.92
Successful kidney trasnplant in patient with positive crossmatch due to autoantibodies. Transplantation (1976) 0.92
Study of HLA antigens in ten multiple-case rheumatoid arthritis families. J Rheumatol (1984) 0.91
Dissimilar evolution of B-locus versus A-locus and class II loci of the HLA region in South American Indian tribes. Tissue Antigens (1997) 0.89
HL-A antigens in mummified pre-Columbian tissues. Science (1974) 0.89
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia. J Immunother (2001) 0.89
DNA typing for class II HLA antigens with allele-specific or group-specific amplification. I. Typing for subsets of HLA-DR4. Hum Immunol (1990) 0.89
Anaerobic metabolism of carbon tetrachloride and formation of catabolically resistant phospholipids. Biochem Pharmacol (1984) 0.89
Evolution of HLA-class I compared to HLA-class II polymorphism in Terena, a South-American Indian tribe. Hum Immunol (1999) 0.89
A comparison of two levels of family-aided assertive community treatment. Psychiatr Serv (1996) 0.88
DQA1*03 subtypes have different associations with DRB1 and DQB1 alleles. Hum Immunol (1994) 0.88
HLA class II DNA typing in two Brazilian populations. Tissue Antigens (1993) 0.87